Patent cliff concerns drive Merck’s $11 billion Prometheus buyout

Patent cliff concerns drive Merck’s $11 billion Prometheus buyout

Deal hoped to stave off investor concerns about expiring patents and diversify product pipeline

Unlock unlimited access to all IAM content